4-Methyl-α-ethylaminopentiophenone

Source: Wikipedia, the free encyclopedia.
4-Methyl-α-ethylaminopentiophenone
Clinical data
Other names4-MEAP; 4-MEAPP; N-Ethyl-4'-methylnorpentedrone; 2-(Ethylamino)-1-(4-methylphenyl)-1-pentanone; 4-Methyl-alpha-ethylaminopentiophenone
Legal status
Legal status
Identifiers
  • 2-(Ethylamino)-1-(4-methylphenyl)-1-pentanone
JSmol)
  • CC1=CC=C(C(C(CCC)NCC)=O)C=C1
  • InChI=1S/C14H21NO/c1-4-6-13(15-5-2)14(16)12-9-7-11(3)8-10-12/h7-10,13,15H,4-6H2,1-3H3
  • Key:IKIANZXWCBSIGA-UHFFFAOYSA-N

4-Methyl-α-ethylaminopentiophenone (4-MEAP) is a designer drug of the cathinone class.[2][3] It is a higher homolog of 4-methylpentedrone (4-MPD) with an ethyl group in place of the methyl group. 4-MEAP has been found in samples of drugs sold as 4-MPD.[4]

In the United States, 4-MEAP is a

Schedule I Controlled Substance.[5]

References

  1. ^ Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-07-25). Archived from the original on 2023-08-27. Retrieved 2023-08-27.
  2. S2CID 40402609
    .
  3. .
  4. .
  5. ^ "Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, α-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-α-PVP in Schedule I". Drug Enforcement Administration. Archived from the original on 2021-04-30. Retrieved 2019-07-31.